Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis
29 Apr 2020
byElaine Soliven
The use of low-dose aspirin was associated with a significantly lower risk of incident hepatocellular carcinoma (HCC) and liver-related mortality in patients with chronic viral hepatitis compared with no aspirin use, according to a recent Swedish study.
Low-dose aspirin may reduce HCC, liver-related death risk in chronic viral hepatitis
29 Apr 2020